2017 Research grant
We were delighted to award 3 projects this year.
1. Dr Bina Kulkarni, Specialty Doctor in Ophthalmology at Queen’s Medical Centre in Nottingham
has been awarded £2,210 for her project ‘Exploring patients’ expectations and preferences for
glaucoma surgery outcomes to facilitate healthcare promoting research’.
By running patient focus groups, Bina and her team will explore what aspects of glaucoma surgery
patients feel want to know about before they have surgery. These findings will then be included in
future glaucoma clinical trials, and patients will have this information available to help them make
their treatment choices.
From left to right: Dr Paul Leighton, Dr Bina Kulkarni, Professor Anthony King
2. Anurag Garg, Clinical Research Fellow and Ophthalmology Registrar at Moorfields Eye Hospital,
London has been awarded £63,626 for his 2 year project ‘Clinical outcomes of Selective Laser
Trabeculoplasty (SLT): a definitive analysis of clinical and patient-reported outcomes, complications
and predictors of success in the LiGHT Trial’.
Anurag and his team will look at whether using SLT to treat glaucoma is a more effective or more
cost effective than using eye drops.
SLT is a quick, painless procedure that drains the eye’s fluid to lower intraocular pressure.
There are none of the uncomfortable side effects often associated with eye drops such as stinging,
itching and blurred vision, and in some patients it can remove the need for drops altogether.
However, use of SLT in the UK is limited due to cost and a lack of understanding of its effectiveness.
Anurag and his team
Mr Gus Gazzard, Principal Investigator, using a slit lamp on a patient
3. Professor Colm O’Brien from the Mater Misericordiae university hospital in Dublin
has been awarded £57,000 for his work on ‘Lamina Cribrosa Cell Bioenergetics and Metabolomics
Colm is looking at changes made to the optic disc and exploring what makes these happen when
someone has glaucoma. It is hoped that the findings will help identify new ways of treating glaucoma
by focussing on the damage to the optic nerve head.